866-997-4948(US-Canada Toll Free)

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

Published By :

GBI Research

Published Date : Oct 2011

Category :

Therapeutic Area

No. of Pages : 80 Pages


GBI Research, the leading business intelligence provider, has released its latest research, Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future which provides insights into the global contraceptives market and market forecasts until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts. 

The report provides an in-depth analysis of the contraceptives most commonly used, such as oral, topical and injectable contraceptives, intrauterine devices, condoms and vaginal rings. The report also examines usage patterns for oral, topical and injectable contraceptives treatment. It also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape, including major companies in the contraceptives market. Finally, the report also includes analysis of mergers and acquisitions (M&A) and licensing agreements that have taken place in the global contraceptives market. 

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts. 

GBI Research analysis shows that revenues are projected to increase from $15.5 billion in 2010 to $19.2 in 2017 at a CAGR of 3.1%. Prescription and OTC contraceptives held an 82% and 18% market share, respectively, in 2010. The intrauterine devices market was valued at $1,370.4m in 2010 and revenues are projected to increase to $1,398.1m in 2017, at a CAGR of 0.3%. However, revenues are expected to decline in 2015 due to the patent expiry of Mirena and the availability of low cost hormonal intrauterine devices. Strategic consolidations through acquisition accounted for 31% of M&A deals.

Scope

  • The report analyzes the market characterization, pipeline analysis and key M&A trends for oral, topical and injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market.
  • Data and analysis on the contraceptives market in leading geographies: the US, the UK, Germany, France, Italy, Spain and Japan.
  • Annualized market data for oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 20022010, with forecasts to 2017.
  • Market data on the therapeutic landscape, which covers oral, topical and injectable contraceptives, and includes market revenues, treatment usage patterns and annual cost of usage.
  • Key drivers and restraints that have had a significant impact on the market.
  • The competitive landscape of the contraceptives market, which includes companies such as Bayer, Johnson & Johnson, Reckitt Benckiser, Church & Dwight and Merck.
  • Key M&A activities and licensing agreements that took place from 20052011 in the contraceptives market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to - 

  • Align your product portfolio to markets with high growth potential.
  • Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
  • Devise a more tailored country strategy through understanding of key drivers and barriers in the contraceptives market.
  • Develop key strategic initiatives by understanding the key focus areas of leading companies.
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
Table of Contents

1 Table of Contents

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7

2 Contraceptives Market to 2017- Introduction 9
2.1 GBI Research Report Guidance 10

3 Contraceptives Market to 2017 - Market Overview 11
3.1 Introduction 11
3.2 Revenue Forecasts for Contraceptives Market 11
3.2.1 Revenues 11
3.2.2 Annual Cost of Usage for Contraceptives 14
3.2.3 Share of Prescription and OTC Contraceptives 15
3.3 Drivers and Barriers for Contraceptives Market 16
3.3.1 Drivers for Contraceptives 16
3.3.2 Barriers for Contraceptives 16

4 Contraceptives Market to 2017- Geographical Landscape 17
4.1 The US 17
4.1.1 Revenue 17
4.1.2 Annual Cost of Therapy for Contraceptives 18
4.2 Top Five Countries of Europe 19
4.2.1 Revenue 19
4.2.2 Annual Cost of Therapy for Contraceptives 20
4.3 Japan 21
4.3.1 Revenue 21
4.3.2 Annual Cost of Therapy for Contraceptives 22

5 Contraceptives Market to 2017 - Therapeutic landscape 23
5.1 Oral Contraceptives 23
5.1.1 Introduction 23
5.1.2 Revenue 23
5.1.3 Annual Cost of Therapy 26
5.1.4 Treatment Usage Patterns 27
5.2 Injectables 29
5.2.1 Introduction 29
5.2.2 Revenue 29
5.2.3 Annual Cost of Therapy 32
5.2.4 Treatment Usage Patterns 33
5.3 Topical Contraceptives 35
5.3.1 Introduction 35
5.3.2 Revenue 35
5.3.3 Annual Cost of Therapy 38
5.3.4 Treatment Usage Patterns 39

6 Contraceptives Market to 2017 - Devices landscape 41
6.1 Vaginal Ring 41
6.1.1 Introduction 41
6.1.2 Revenue 41
6.1.3 Geographical Segmentation 43
6.1.4 Annual Cost of Usage 45
6.2 Intrauterine Devices 46
6.2.1 Introduction 46
6.2.2 Revenue 46
6.2.3 Copper Intrauterine Device and Hormonal Intrauterine Device Share 47
6.2.4 Geographical Segmentation 48
6.2.5 Annual Cost of Usage 50
6.3 Condoms 51
6.3.1 Introduction 51
6.3.2 Revenue 51
6.3.3 Geographical Segmentation 52
6.3.4 Annual Cost of Usage 54

7 Contraceptives Market to 2017 - Pipeline Analysis 55
7.1 Introduction 55
7.2 Profiles of Promising Drugs in the Global Contraceptives Market 58
7.2.1 AG200-15 58
7.2.2 Yaz Flex 58
7.2.3 Pill-Plus 59

8 Contraceptives Market to 2017 - Competitive Landscape 60

8.1 Market Share Analysis: Contraceptives Market 60
8.2 Drug Profile of Major Marketed Contraceptives 60
8.2.1 Yaz/ Yasmin 61
8.2.2 Mirena 61
8.2.3 Nuvaring 61
8.3 Competitive Profiling 62
8.3.1 Bayer 62
8.3.2 Johnson & Johnson 64
8.3.3 Church & Dwight 65
8.3.4 Merck 66
8.3.5 Reckitt & Benckiser 67

9 Contraceptives Market to 2017 - M&A Landscape 68
9.1 M&A Landscape 68
9.1.1 M&A Deals by Year 68
9.1.2 M&A Deals by Value 69
9.1.3 M&A Deals by Geography 70
9.1.4 M&A Deals by Deal Type 71
9.1.5 M&A Deals by Deal Sub-Type 72
9.2 R&D Licensing Agreements 73
9.2.1 Deals by Year 73
9.2.2 Deals by Geography 74
9.2.3 Deals by Value 75
9.3 Co-Development Agreements 76
9.3.1 Deals by Year 76
9.3.2 Deals by Geography 76

10 Contraceptives Market to 2017 - Appendix 77
10.1 Market Definitions 77
10.2 Abbreviations 77
10.3 Research Methodology 77
10.3.1 Coverage 77
10.3.2 Secondary Research 78
10.3.3 Primary Research 78
10.3.4 Section Methodology 78
10.3.5 Expert Panel Validation 80
10.4 Contact Us 80
10.5 Disclaimer 80
10.6 Sources 80

List of Table


Table 1: Contraceptives Market, Global, Revenue, ($bn), 2002 - 2010
Table 2: Contraceptives Market, Global, Revenue Forecasts, ($bn), 2010 - 2017
Table 3: Contraceptives Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 4: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 5: Contraceptives Market, Global, Annual Cost of Usage, ($), 2002 - 2010
Table 6: Contraceptives Market, Global, Annual Cost of Usage, ($), 2010 - 2017
Table 7: Contraceptives Market, The US, Revenue, ($bn), 2002 - 2010
Table 8: Contraceptives Market, The US, Revenue Forecasts, ($bn), 2010 - 2017
Table 9: Contraceptives Market, The US, Annual Cost of Usage, ($), 2002 - 2010
Table 10: Contraceptives Market, The US, Annual Cost of Usage, ($), 2010 - 2017
Table 11: Contraceptives Market, Top Five Countries of Europe, Revenue, ($bn), 2002 - 2010
Table 12: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts, ($bn), 2010 - 2017
Table 13: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2002 - 2010
Table 14: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2010 - 2017
Table 15: Contraceptives Market, Japan, Revenue, ($m), 2002 - 2010
Table 16: Contraceptives Market, Japan, Revenue Forecasts, ($m), 2010 - 2017
Table 17: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2002 - 2010
Table 18: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2010 - 2017
Table 19: Oral Contraceptives Market, Global, Revenue, ($m), 2002 - 2010
Table 20: Oral Contraceptives Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 21: Oral Contraceptives Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 22: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 23: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2010
Table 24: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2010 - 2017
Table 25: Oral Contraceptives Market, Global, Treatment Usage Patterns, (Million), 2002 - 2010
Table 26: Oral Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (Million), 2010 - 2017
Table 27: Injectables Market, Global, Revenue, ($m), 2002 - 2010
Table 28: Injectables Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 29: Injectables Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 30: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 31: Injectables Market, Global, Annual Cost of Therapy, ($), 2002 - 2010
Table 32: Injectables Market, Global, Annual Cost of Therapy, ($), 2010 - 2017
Table 33: Injectables Market, Global, Treatment Usage Patterns, (\'000), 2002 - 2010
Table 34: Injectables Market, Global, Treatment Usage Patterns Forecasts, (\'000), 2010 - 2017
Table 35: Topical Contraceptives Market, Global, Revenue, ($m), 2002 - 2010
Table 36: Topical Contraceptives Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 37: Topical Contraceptives Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 38: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 39: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2010
Table 40: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2010 - 2017
Table 41: Topical Contraceptives Market, Global, Treatment Usage Patterns, (\'000), 2002 - 2010
Table 42: Topical Contraceptives Market, Global, Treatment Usage Patterns, (\'000), 2010 - 2017
Table 43: Vaginal Ring Market, Global, Revenue, ($m), 2002 - 2010
Table 44: Vaginal Ring Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 45: Vaginal Ring Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 46: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 47: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2002 - 2010
Table 48: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2010 - 2017
Table 49: Intrauterine Devices Market, Global, Revenue, ($m), 2002 - 2010
Table 50: Intrauterine Devices Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 51: Intrauterine Devices Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 52: Intrauterine Devices Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 53: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2002 - 2010
Table 54: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2010 - 2017
Table 55: Condoms Market, Global, Revenue, ($m), 2002 - 2010
Table 56: Condoms Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 57: Condoms Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 58: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 59: Condoms Market, Global, Annual Cost of Usage, ($), 2002 - 2010
Table 60: Condoms Market, Global, Annual Cost of Usage, ($), 2010 - 2017
Table 61: Contraceptives Market, Global, Product Pipeline by Phase, 2011
Table 62: Contraceptives Market, Global, Pipeline, Pre-Clinical Stage Molecules, 2011
Table 63: Contraceptives Market, Global, Pipeline, Discovery Stage Molecules, 2011
Table 64: Contraceptives Market, Global, Pipeline, Phase I Molecules, 2011
Table 65: Contraceptives Market, Global, Pipeline, Phase II Molecules, 2011
Table 66: Contraceptives Market, Global, Pipeline, Phase III Molecules, 2011
Table 67: Contraceptives Market, Global, Pipeline, NDA Filed Molecules, 2011
Table 68: Contraceptives Market, Global, Revenues of Major Marketed Contraceptives, ($m), 2010
Table 69: Contraceptives Market, Global, M&A Deals by Value, 2000 - 2011
Table 70: Contraceptives Market, Global, M&A Deals by Geography, 2000 - 2011
Table 71: Contraceptives Market, Global, M&A Deals by Deal Type, 2000 - 2011
Table 72: Contraceptives Market, Global, Deals by Deal Sub-Type, 2000 - 2011
Table 73: Contraceptives Market, Global, Licensing Agreements by Geography, 2004 - 2011
Table 74: Contraceptives Market, Global, Licensing Agreements by Value, 2004 - 2011

List of Chart


Figure 1: Contraceptives Market, Global, Revenue Forecasts, ($bn), 2002 - 2017 11
Figure 2: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($bn), 2002 - 2017 12
Figure 3: Contraceptives Market, Global, Annual Cost of Usage, ($), 2002 - 2017 14
Figure 4: Contraceptives Market, Global, Share of Prescription and OTC Contraceptives, (%), 2010 15
Figure 5: Contraceptives Market, Global, Drivers and Barriers, 2011 16
Figure 6: Contraceptives Market, The US, Revenue Forecasts, ($bn), 2002 - 2017 17
Figure 7: Contraceptives Market, The US, Annual Cost of Usage, ($), 2002 - 2017 18
Figure 8: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts, ($bn), 2002 - 2017 19
Figure 9: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2002 - 2017 20
Figure 10: Contraceptives Market, Japan, Revenue Forecasts, ($m), 2002 - 2017 21
Figure 11: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2002 - 2017 22
Figure 12: Oral Contraceptives Market, Global, Revenue Forecasts, ($m), 2002 - 2017 23
Figure 13: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 24
Figure 14: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2017 26
Figure 15: Oral Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (Million), 2002 - 2017 27
Figure 16: Injectables Market, Global, Revenue Forecasts, ($m), 2002 - 2017 29
Figure 17: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 30
Figure 18: Injectables Market, Global, Annual Cost of Therapy, ($), 2002 - 2017 32
Figure 19: Injectables Market, Global, Treatment Usage Patterns Forecasts, (000), 2002 - 2017 33
Figure 20: Topical Contraceptives Market, Global, Revenue Forecasts, ($m), 2002 - 2017 35
Figure 21: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 36
Figure 22: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2017 38
Figure 23: Topical Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (000), 2002 - 2017 39
Figure 24: Vaginal Ring Market, Global, Revenue Forecasts, ($m), 2002 - 2017 41
Figure 25: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 43
Figure 26: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2002 - 2017 45
Figure 27: Intrauterine Devices Market, Global, Revenue Forecasts, ($m), 2002 - 2017 46
Figure 28: Intrauterine Devices Market, Global, Share of Hormonal and Copper Intrauterine Device, (%), 2010 47
Figure 29: Intrauterine Devices Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 48
Figure 30: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2002 - 2017 50
Figure 31: Condoms Market, Global, Revenue Forecasts, ($m), 2002 - 2017 51
Figure 32: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 52
Figure 33: Condoms Market, Global, Annual Cost of Usage, ($), 2002 - 2017 54
Figure 34: Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011 55
Figure 35: Contraceptives Market, Global, Market Share Analysis, (%), 2011 60
Figure 36: Contraceptives Market, Global, Bayer Company Profile, 2011 62
Figure 37: Contraceptives Market, Global, Bayer, SWOT Analysis, 2011 63
Figure 38: Contraceptives Market, Global, Johnson & Johnson Company Profile, 2011 64
Figure 39: Contraceptives Market, Global, Johnson & Johnson, SWOT Analysis, 2011 64
Figure 40: Contraceptives Market, Global, Church & Dwight Company Profile, 2011 65
Figure 41: Contraceptives Market, Global, Church & Dwight, SWOT Analysis, 2011 65
Figure 42: Contraceptives Market, Global, Merck Company Profile, 2011 66
Figure 43: Contraceptives Market, Global, Merck, SWOT Analysis, 2011 66
Figure 44: Contraceptives Market, Global, Reckitt Benckiser Company Profile, 2011 67
Figure 45: Contraceptives Market, Global, Reckitt Benckiser, SWOT Analysis, 2011 67
Figure 46: Contraceptives Market, Global, M&A Deals by Year, 2000 - 2011 68
Figure 47: Contraceptives Market, Global, M&A Deals by Value (%), 2000 - 2011 69
Figure 48: Contraceptives Market, Global, M&A Deals by Geography (%), 2000 - 2011 70
Figure 49: Contraceptives Market, Global, M&A Deals by Deal Type (%), 2000 - 2011 71
Figure 50: Contraceptives Market, Global, Deals by Deal Sub-Type (%), 2000 - 2011 72
Figure 51: Contraceptives Market, Global, Licensing Agreements by Year, 2004 - 2011 73
Figure 52: Contraceptives Market, Global, Licensing Agreements by Geography (%), 2004 - 2011 74
Figure 53: Contraceptives Market, Global, Licensing Agreements by Value (%), 2004 - 2011 75
Figure 54: Contraceptives Market, Global, Co-Development Agreements by Year, 2006 - 2011 76

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *